InvestorsHub Logo
Followers 37
Posts 7086
Boards Moderated 0
Alias Born 05/23/2011

Re: trader59 post# 39421

Monday, 09/12/2022 5:46:23 PM

Monday, September 12, 2022 5:46:23 PM

Post# of 44139
You expect uplisting to be approved by regulators without IND?

Can’t see why the regulators will approve uplist based on offering price alone especially with no revenue

I have doubts investors will pay $7 a share without some prospect of bringing a drug to market. They don’t seem to be willing to pay even .04

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CUBT News